Actively Recruiting
PEG3350 vs Senna After Urogyn Surgery
Led by St. Joseph's Health, New York · Updated on 2025-05-28
254
Participants Needed
1
Research Sites
114 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to evaluate whether polyethylene glycol 3350 (PEG3350) versus senna is better at relieving postoperative constipation after urogynecologic surgery. The main questions it aims to answer are: What number of patients taking PEG3350 have obstructed defecation syndrome (ODS), a form of constipation, vs those taking senna in the week after urogynecologic surgery? What patient-level and procedure-level characteristics are associated with postoperative ODS, in patients taking PEG3350 vs senna? participants will: Take their randomized medication daily for seven days after surgery Fill out an ODS questionnaire before and one week after surgery Complete a daily bowel diary for 7 days after surgery
CONDITIONS
Official Title
PEG3350 vs Senna After Urogyn Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women scheduled for urogynecologic surgery for pelvic organ prolapse and/or stress urinary incontinence
- Age 18 years or older
You will not qualify if you...
- Undergoing concomitant bowel surgery such as colonic resection, anal sphincter repair, rectovaginal fistula repair, or rectopexy
- Placement of a sacral neuromodulation device alone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St. Joseph's Health Hospital
Syracuse, New York, United States, 13203
Actively Recruiting
Research Team
K
Keila S Muniz, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here